Maryam Mokhtarzadeh

Maryam joined Regenxbio as Senior Director for Regulatory Strategy earlier this year building on her prior leadership experience at AbbVie as Medical Director of Clinical Development. Before joining industry, Maryam spent over a decade at FDA where she held leadership roles in the Office of the Commissioner, CDRH, the Office of Combination Products, and served as the FDA IRB Chairman. While at FDA, Maryam also participated in direct patient care in the Ophthalmic Genetics and Visual Function Branch of the NEI/NIH. Maryam is a board-certified ophthalmologist and graduated from the Johns Hopkins University School of Medicine and Princeton University.